摘要
目的分析2012-2014年宜昌市结核病医防合作实施效果,为今后结核病防治提供参考和建议。方法收集并分析2012-2014年宜昌市肺结核患者发现、初诊查痰、转诊追踪、耐药发现等指标。结果实施医防合作3年来,肺结核患者发现、治疗、管理各项指标均保持在较高水平,涂阴培养率从1.93%提高到73.95%,培养阳性患者数逐年增加;耐药筛查率从12.05%提升至96.97%,2014年耐药患者发现数是2012年的3.56倍。结论宜昌市结核病医防合作取得明显成效,但仍需提升定点医院诊疗水平。
Objective To analyze the effect of the new anti-TB-cooperation system for TB prevention within three years,and provide reference and suggestion for TB control in the future. Methods To collect and analyze the data of the discovery of TB cases,sputum examination at the first diagnosis,referral and tracing of tuberculosis,the discovery of MDR-TB patients in Yichang City from 2012 to2014. Results After the three-year implementation of the new medical anti-cooperation system, the discovery, treatment,management of the indicators were kept at a high level,the rate of smear-negative patients increased from1. 93% to 73. 95%,increased 38 times; the smear-positive patients increased 37 times; the screening of the drug-resistant patients was 9. 6 times in 2014 as compared with that in 2012,the rate of screening increased from 12. 05% to 96. 97%,the screening of the drug-resistant patients was3. 56 times as compared with that in 2012. Conclusion Significant outcome was achieved after the implementation of the new antiTB co-operation system,however,the level of diagnosis and treatment in the designated medical hospitals still need to be improved to maintain sustainable development.
出处
《公共卫生与预防医学》
2015年第6期19-21,共3页
Journal of Public Health and Preventive Medicine
基金
中国国家卫生和计划生育委员会-比尔及梅琳达.盖茨基金会结核病防治合作项目(51914)
关键词
结核病防治
医防合作
TB control
Cooperation for treatment and prevention